Retatrutide — 20mg
$149.99 CAD
Your first order? Save 20%. Enter code firstorder20 at checkout.
Retatrutide (LY3437943) is an investigational peptide studied for its activity at GIP, GLP-1 and glucagon receptors.
Single vial · 20mg. For laboratory research only; not for human or veterinary use.
Retatrutide 20mg — Full COA
VialTests · Report VT-2026-001735 · Lot 7382-26
Issued
View full COA — 2-page PDF (opens in a new tab) · Download original PDF
Original report and verification record, reproduced without changes. Results apply to the sample tested; confirm the lot match before applying them to a vial. Verify with VialTests (opens in a new tab).
Laboratory results
Batch 11/2025
- Reported purity
- 99.846%
- Retatrutide
- 21.09 mg
Tested by Janoshik Analytical · .
Results apply only to the material tested.
Verification enquiries: elmntpep@proton.me
Retatrutide (LY3437943) research product
Retatrutide is an investigational peptide studied as a combined agonist of the GLP-1, GIP, and glucagon receptors. It is used in controlled laboratory models examining multi-receptor signaling and metabolic pathway interactions.
Product specifications
- Compound: Retatrutide (LY3437943)
- Labeled amount: 20mg
- Format: Single research vial
- Intended use: Laboratory research only
Research focus
Common areas of controlled laboratory investigation include:
- GLP-1, GIP, and glucagon receptor signaling
- Multi-receptor pathway interactions
- Incretin and metabolic signaling models
What you receive
Each order includes one research vial labeled at 20mg.
Use compound-specific literature and an appropriate analytical method for the research question being studied. Browse related products in GLP and Weight Loss, or review the research peptide supplier evaluation guide for help comparing suppliers.
Retatrutide research guide: Review the triple-receptor profile, molecular design, evidence layers, and analytical identity considerations.
Testing documentation
Published testing for this listing: Batch 11/2025 — report 91696. Each ELMNTPEP-prepared summary includes the laboratory, date and reported results. Results describe the material tested, not every vial in stock. Confirm the lot connection before applying a result to your product.
Before checkout, review ELMNTPEP shipping information and payment options.
Retatrutide
Retatrutide is an investigational peptide. A one-to-one PubChem identity profile is not displayed because the reference record could not be verified with sufficient confidence.
Reference values describe the named compound in the linked public database. They do not identify, assay, or verify a specific vial or batch. Product-specific documents are published separately when available.
Product questions
What is included with this product?
Retatrutide comes as a single research vial containing 20mg.
Is this product currently available?
This product is currently in stock. Availability is checked again at checkout. Backorders are not accepted.
Where can I find testing documentation?
Open Batch 11/2025 — report 91696 in our testing library. Check the report identifiers and confirm the lot match; matching strength alone is not enough.
Research use notice
For laboratory research use only. Not for human or veterinary use. This listing does not provide medical, dosing, administration, or therapeutic guidance.
Additional information
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.